# Late Phase II Study of TS-142 in Patients with Insomnia

> **NCT04469023** · PHASE2 · COMPLETED · sponsor: **Taisho Pharmaceutical Co., Ltd.** · enrollment: 179 (actual)

## Conditions studied

- Patients with Insomnia

## Interventions

- **DRUG:** TS-142

## Key facts

- **NCT ID:** NCT04469023
- **Lead sponsor:** Taisho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-09
- **Primary completion:** 2021-11-16
- **Final completion:** 2021-11-16
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04469023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04469023, "Late Phase II Study of TS-142 in Patients with Insomnia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04469023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*